CHEMOTHERAPY WITH MAXIMALLY TOLERABLE DOSES OF VP-16-213 AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY GERM-CELL TUMORS

POM MULDER; EGE DEVRIES; HS KOOPS; T SPLINTER; A MAAS; S VANDERGEEST; NH MULDER; DT SLEIJFER

CHEMOTHERAPY WITH MAXIMALLY TOLERABLE DOSES OF VP-16-213 AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY GERM-CELL TUMORS

POM MULDER^*, EGE DEVRIES, HS KOOPS, T SPLINTER, A MAAS, S VANDERGEEST, NH MULDER, DT SLEIJFER

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

38 Citations (Scopus)

Original language	English
Pages (from-to)	675-679
Number of pages	5
Journal	European journal of cancer & clinical oncology
Volume	24
Issue number	4
Publication status	Published - Apr-1988

Handle.net

Persistent link

Cite this

MULDER, POM., DEVRIES, EGE., KOOPS, HS., SPLINTER, T., MAAS, A., VANDERGEEST, S., MULDER, NH., & SLEIJFER, DT. (1988). CHEMOTHERAPY WITH MAXIMALLY TOLERABLE DOSES OF VP-16-213 AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY GERM-CELL TUMORS. European journal of cancer & clinical oncology, 24(4), 675-679.

@article{aeffe3e55ad045dda405153cb41ad89c,

title = "CHEMOTHERAPY WITH MAXIMALLY TOLERABLE DOSES OF VP-16-213 AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY GERM-CELL TUMORS",

author = "POM MULDER and EGE DEVRIES and HS KOOPS and T SPLINTER and A MAAS and S VANDERGEEST and NH MULDER and DT SLEIJFER",

year = "1988",

month = apr,

language = "English",

volume = "24",

pages = "675--679",

journal = "European journal of cancer & clinical oncology",

issn = "0277-5379",

publisher = "PERGAMON-ELSEVIER SCIENCE LTD",

number = "4",

}

MULDER, POM, DEVRIES, EGE, KOOPS, HS, SPLINTER, T, MAAS, A, VANDERGEEST, S, MULDER, NH & SLEIJFER, DT 1988, 'CHEMOTHERAPY WITH MAXIMALLY TOLERABLE DOSES OF VP-16-213 AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY GERM-CELL TUMORS', European journal of cancer & clinical oncology, vol. 24, no. 4, pp. 675-679.

CHEMOTHERAPY WITH MAXIMALLY TOLERABLE DOSES OF VP-16-213 AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY GERM-CELL TUMORS. / MULDER, POM; DEVRIES, EGE; KOOPS, HS et al.
In: European journal of cancer & clinical oncology, Vol. 24, No. 4, 04.1988, p. 675-679.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - CHEMOTHERAPY WITH MAXIMALLY TOLERABLE DOSES OF VP-16-213 AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY GERM-CELL TUMORS

AU - MULDER, POM

AU - DEVRIES, EGE

AU - KOOPS, HS

AU - SPLINTER, T

AU - MAAS, A

AU - VANDERGEEST, S

AU - MULDER, NH

AU - SLEIJFER, DT

PY - 1988/4

Y1 - 1988/4

M3 - Article

SN - 0277-5379

VL - 24

SP - 675

EP - 679

JO - European journal of cancer & clinical oncology

JF - European journal of cancer & clinical oncology

IS - 4

ER -